Cardiovascular Risk Factor and Atherosclerosis in Rheumatoid Arthritis (RA)

Area of Science:

• Rheumatology
• Cardiology
• Inflammation Research

Background:

• Rheumatoid arthritis (RA) is linked to increased cardiovascular disease (CVD) risk due to chronic inflammation and traditional risk factors.
• Managing RA effectively is crucial for mitigating associated CVD risks.

Purpose of the Study:

• To review advancements in managing RA-specific and traditional risk factors.
• To assess the impact of RA treatments on cardiovascular outcomes.

Main Methods:

• Literature review of recent studies on RA management and CVD.
• Analysis of biomarkers (e.g., CRP, Lipoprotein(a)) and imaging for cardiovascular risk stratification.
• Evaluation of cardiovascular benefits of RA treatments.

Main Results:

• RA management advancements correlate with reduced CVD risk trends.
• Biomarkers and imaging tools improve risk stratification in RA patients.
• Effective RA treatments yield significant cardiovascular benefits, with variations in high-risk subgroups.

Conclusions:

• RA treatment lowers cardiovascular events; standard management of hypertension, diabetes, and hypercholesterolemia is effective.
• RA is a CVD risk-enhancing state, but specific RA-related targets for blood pressure, blood sugar, and lipids are absent.